The estimated Net Worth of Lucille S Salhany is at least $11 Tisíc dollars as of 2 March 2011. Lucille Salhany owns over 1,860 units of 22nd Century Inc stock worth over $10,975 and over the last 22 years Lucille sold XXII stock worth over $0.
Lucille has made over 5 trades of the 22nd Century Inc stock since 2005, according to the Form 4 filled with the SEC. Most recently Lucille exercised 1,860 units of XXII stock worth $24,998 on 2 March 2011.
The largest trade Lucille's ever made was exercising 29,000 units of 22nd Century Inc stock on 24 August 2005 worth over $428,910. On average, Lucille trades about 5,069 units every 100 days since 2003. As of 2 March 2011 Lucille still owns at least 38,643 units of 22nd Century Inc stock.
You can see the complete history of Lucille Salhany stock trades at the bottom of the page.
Lucille's mailing address filed with the SEC is C/O 22ND CENTURY GROUP, INC., 500 SENECA STREET, SUITE 507, BUFFALO, NY, 14204.
Over the last 11 years, insiders at 22nd Century Inc have traded over $3,035,006 worth of 22nd Century Inc stock and bought 652,225 units worth $737,196 . The most active insiders traders include Andrew Arno, Joseph Pandolfino a Michael Zercher. On average, 22nd Century Inc executives and independent directors trade stock every 80 days with the average trade being worth of $16,372. The most recent stock trade was executed by Lawrence Firestone on 30 May 2024, trading 9,000 units of XXII stock currently worth $9,810.
with the mission of reducing the harm caused by smoking, 22nd century is a plant biotechnology company whose proprietary technology allows for the levels of nicotine in the tobacco plant to be decreased or increased through genetic engineering and plant breeding. goodrich tobacco company and hercules pharmaceuticals are wholly-owned subsidiaries focusing on (i) premium cigarettes and potentially reduced risk tobacco products (with up to 97% less nicotine than conventional cigarettes), and (ii) the x-22 prescription smoking cessation aid in development. 22nd century's technology also allows the levels of cannabinoids to be decreased or increased in the cannabis plant.
22nd Century Inc executives and other stock owners filed with the SEC include: